MapmyGenome receives NABL accreditation setting standards in genetic testing

The NABL accreditation is a rigorous process that evaluates laboratories based on their technical competence, quality management systems, and adherence to international standards.

0
90
New Delhi: Mapmygenome™, a leading provider of personalized health and wellness solutions through genomic tests, has announced its accreditation by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
As per the company, this significant achievement underscores its unwavering commitment to delivering high-quality and reliable services to its consumers.
The NABL accreditation is a rigorous process that evaluates laboratories based on their technical competence, quality management systems, and adherence to international standards. Earning this accreditation demonstrates MapmyGenome’s dedication to maintaining the highest levels of accuracy, reliability, and efficiency in every aspect of its operations, from sample handling and analysis to data interpretation and reporting.
“At MapmyGenome™, we have always prioritized the delivery of accurate and actionable genetic information to empower individuals in managing their health and well-being,” said Anu Acharya, CEO and Founder of MapmyGenome™.
“Obtaining NABL accreditation is a significant milestone for us, as it reflects our commitment to the highest standards of quality and reliability in genetic testing. This achievement further strengthens our position as a trusted partner in personalized healthcare.”
NABL accreditation not only validates the technical competence of Mapmygenome but also enhances the confidence of healthcare professionals, patients, and partners in the accuracy of the company’s genetic testing services. The accreditation is a recognition of Mapmygenome’s dedication to continuous improvement and its pursuit of excellence in preventive and clinical genomics tests.